Wayland Group Corp
Wayland Group Corp. produces and sells medical marijuana in Canada and internationally. The company was founded in 2013 and is based Burlington, Canada.
Wayland Group Corp (MRRCF) - Net Assets
Latest net assets as of September 2018: $124.11 Million USD
Based on the latest financial reports, Wayland Group Corp (MRRCF) has net assets worth $124.11 Million USD as of September 2018.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($155.03 Million) and total liabilities ($30.92 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $124.11 Million |
| % of Total Assets | 80.06% |
| Annual Growth Rate | 142.99% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Wayland Group Corp - Net Assets Trend (2014–2017)
This chart illustrates how Wayland Group Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wayland Group Corp (2014–2017)
The table below shows the annual net assets of Wayland Group Corp from 2014 to 2017.
| Year | Net Assets | Change |
|---|---|---|
| 2017-12-31 | $49.10 Million | +2134.75% |
| 2016-12-31 | $-2.41 Million | -618.07% |
| 2015-12-31 | $-336.06K | -109.83% |
| 2014-12-31 | $3.42 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Wayland Group Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6242601400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2017)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $98.76 Million | 201.14% |
| Other Comprehensive Income | $2.81 Million | 5.73% |
| Other Components | $12.39 Million | 25.24% |
| Total Equity | $49.10 Million | 100.00% |
Wayland Group Corp Competitors by Market Cap
The table below lists competitors of Wayland Group Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
INTRA ENERGY
BE:ARI
|
$1.40K |
|
South Valley Cement
EGX:SVCE
|
$1.40K |
|
Egyptian Satellites (NileSat)
EGX:EGSA
|
$1.40K |
|
Magma Silver Corp.
V:MGMA
|
$1.40K |
|
Gharibwal Cement Ltd
KAR:GWLC
|
$1.40K |
|
Laser Master International Inc
PINK:LMTI
|
$1.40K |
|
METALS EXPLORATION
BE:MJ4
|
$1.40K |
|
Stylers Int.
KAR:STYLERS
|
$1.39K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wayland Group Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2016 to 2017, total equity changed from -2,413,153 to 49,101,727, a change of 51,514,880.
- Net loss of 51,627,389 reduced equity.
- Share repurchases of 40,010,923 reduced equity.
- Other comprehensive income decreased equity by 5,460,342.
- Other factors increased equity by 148,613,534.
Equity Change Factors (2016 to 2017)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-51.63 Million | -105.14% |
| Share Repurchases | $40.01 Million | -81.49% |
| Other Comprehensive Income | $-5.46 Million | -11.12% |
| Other Changes | $148.61 Million | +302.66% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Wayland Group Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.00 | $0.00 | x |
| 2015-12-31 | $-0.06 | $0.00 | x |
| 2016-12-31 | $-0.06 | $0.00 | x |
| 2017-12-31 | $0.71 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wayland Group Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -105.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2079.37%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.52x
- Recent ROE (-105.14%) is below the historical average (-41.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -62.45% | -482163.66% | 0.00x | 1.94x | $-2.48 Million |
| 2015 | 0.00% | -3.68% | 401.62x | 0.00x | $-39.04K |
| 2016 | 0.00% | -204.32% | 0.17x | 0.00x | $-6.02 Million |
| 2017 | -105.14% | -2079.37% | 0.03x | 1.52x | $-56.54 Million |
Industry Comparison
This section compares Wayland Group Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wayland Group Corp (MRRCF) | $124.11 Million | -62.45% | 0.25x | $1.40K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |